株式会社カイゴメディアへの出資を決定

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]

株式会社ブレイゾン・セラピューティクスへの追加出資を決定

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]

タグシクス・バイオ株式会社への追加出資を決定

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]

Telexistence inc.への追加出資を決定

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]

東大関連ベンチャー×無料オンラインセミナー開催「ロボット×AIの最新テックで、ヒトの労働環境改善に挑む！」6/24(木)19:30~

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]

Heartseed raises $37 Million in series C funding to accelerate the development of iPSC-derived stem cell therapy for heart failure

TOKYO, JAPAN, June 11, 2021 – Heartseed Inc., a Tokyo-based biotechnology company developing iPSC-derived card […]

LiberoThera Closes 535 Million JPY Financing to Develop GPCR-targeting Therapeutics

Tokyo, Japan, May, 14, 2021 – LiberoThera Co., Ltd. (“LiberoThera” or the “Company”), a biotechnology company […]

SBIグループ、東大IPCとの協業開始に関するお知らせ

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]

東大IPCと三菱地所、丸の内等におけるオープンイノベーションの促進に向けた協業を開始

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]

東大IPCと東京大学が共催するインキュベーションプログラム 「東大IPC 1st Round」 を４大学共催プログラム「1stRound」に　～筑波大学、東京医科歯科大学、東京工業大学、東京大学、東大IPCが合意～

Sorry, this entry is only available in Japanese. For the sake of viewer convenience, the content is shown belo […]